BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HealtheTech, Inc. (HETC) Announces Changes In Finance Staffing; Steve Webb Had Resigned As Chief Financial Officer


10/19/2005 5:09:43 PM

GOLDEN, Colo., Jan. 16 /PRNewswire-FirstCall/ -- HealtheTech, Inc. , a Colorado-based company that develops and markets technologically advanced and proprietary handheld medical devices and software for the measurement of resting metabolic rate and nutrition monitoring, announced today that Steve Webb had resigned as Chief Financial Officer effective December 31st and that Sandy MacPherson, the Company's President and COO, will act as principal financial officer until the company hires a Vice President of Finance to fill the role.

"Steve made significant contributions to HealtheTech during his tenure here," said James W. Dennis, HealtheTech's Chairman and Chief Executive Officer. "Our recent operational restructuring and smaller size led both Steve and myself to the conclusion that HealtheTech simply did not require a financial officer of Steve's caliber and experience."

Steve Webb commented, "I believe the company's streamlined organization, better focus, and new business model has set the stage for long-term success. I will continue to be a strong supporter of and investor in HealtheTech."

About HealtheTech, Inc.

HealtheTech, Inc., headquartered in Golden, CO., develops and markets technologically advanced and proprietary handheld medical devices and software for the measurement of resting metabolic rate and monitoring of nutrition. HealtheTech's breakthrough products assist healthcare professionals and wellness advisors in the areas of medical nutrition therapy, weight management and fitness, to provide cost-effective and personalized nutrition monitoring and weight management tools. HealtheTech's product line includes hardware and software that allow consumers to monitor their health and nutrition simply and easily. The company's common stock is traded on the Nasdaq National Market under the symbol "HETCD." For more information, please visit http://www.healthetech.com/

This release contains "forward-looking" statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to the safe harbors created thereby. Such forward-looking statements, including statements regarding the Company's future staffing plans and effects of organizational changes and new business model contained in this release, are based on a number of assumptions. Such assumptions are also based upon internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions, such as prices, supply and demand and cost of raw materials. Actual results could differ materially from those projected in the forward- looking statement as a result of known and unknown risk factors and uncertainties. Reference is made to the discussion of risk factors contained in HealtheTech's filings with the Securities and Exchange Commission. HealtheTech undertakes no obligation to subsequently update or revise the forward-looking statements made in this news release to reflect events or circumstances after the date of this release.

HealtheTech, Inc.

CONTACT: Darlene Braden, Investor Relations of HealtheTech, Inc.,+1-303-526-5085, ext. 316, dbraden@healthetech.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES